Get notified of page updates

Search Results: Treatment + Prostate Cancer + Newly Diagnosed (1 results)

New Search
PRINTER FRIENDLY PAGE 1 through 1 of 1
SWOG Cancer Research Network

Treatment
Treatment before surgery for people with high-risk prostate cancer and an inherited BRCA1 or BRCA2 gene mutation

Carboplatin Chemotherapy before Surgery for Patients with High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

This study tests how well carboplatin before surgery works in treating patients with high-risk prostate cancer who have inherited BRCA1 or BRCA2 gene mutations. The purpose of the study is to treat men with BRCA1 or BRCA2 mutations who are at higher risk of prostate cancer after surgery (removal of the prostate) compared to patients without these mutations.

Clinicaltrials.gov identifier: NCT05806515
Additional Results on Clinicaltrials.gov Treatment + Prostate Cancer + Newly Diagnosed + test
4 results
Clinical Trial Official Title
NCT05155046 18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
NCT05806515 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
NCT03456843 Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer
NCT06130995 Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

Sponsored By